Tag: emerging technologies

Blogs

Meet the Silicon Valley Donors Backing California’s Redistricting Push

In the latest sign that Silicon Valley titans are increasingly throwing their weight behind political issues, Netflix co-founder Reed Hastings has contributed $2 million to support Gov. Gavin Newsom’s Proposition 50 campaign. The move is the latest underscoring how Silicon Valley’s deep-pocketed executives are increasingly wielding influence in California politics and beyond. The November ballot […]

Blogs

Touted As The Tesla-Killer, Lucid Scrambles to Stay On The NASDAQ

Beleaguered electric vehicle company Lucid Motors (LCID) has implemented a reverse stock split, consolidating shares to meet NASDAQ’s $1 minimum trading price and prevent delisting. As of Friday, Lucid’s share price was down over 96% from its all-time high of $64.86, reached in February 2021.  While this move may protect the company from being removed […]

Blogs

Meta Stock Drops On News It Used Taylor Swift As Chatbot Without Permission

Meta has ignited a firestorm after chatbots created by the company and its users impersonated Taylor Swift and other celebrities across Facebook, Instagram, and WhatsApp without their permission. Shares of the company have already dropped more than 12% in after hours trading as news of the debacle spread. Scarlett Johansson, Anne Hathaway, and Selena Gomez […]

Blogs

AI Is Golden or ‘Not Rational’: Wall Street’s Battle With Which Road to Take

As investments in artificial intelligence continue to soar, some analysts are raising alarms about a looming bubble that could burst and trigger broader market declines. Others, however, say they’ve never been so sure that it is a growing opportunity. So who is right? Well, on Wall Street, there’s a pick-your-flavor opinion for whatever it is […]

Blogs

‘The Magic of Burning Man’: Elon Musk’s DOGE Point Man is Now An MDMA Consigliere

Antonio Gracias, Elon Musk’s close ally and Tesla (TSLA) board member, has pivoted to a controversial takeover of Lykos Therapeutics, a biotech firm developing MDMA-based therapies once rejected by the FDA for safety concerns, The Guardian reports. As the psychedelics industry inches toward mainstream acceptance, new developments reveal how politics, science, and industry interests are […]

Back To Top